title: Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity.
abstract: Cell contact with the extracellular matrix component hyaluronic acid (HA) plays an important role in many developmental, physiological, and pathological processes, although the regulation of this contact is poorly understood. CD44 proteins carry an amino acid motif that mediates affinity to HA. Artificial clustering of the smallest 85-kD isoform of CD44 (CD44s) has previously been shown to promote binding of the protein to soluble HA (Lesley, J., R. Hyman, and P.W. Kincade. 1993. Adv. Immunol. 54:271-335; Persche, A., J. Lesley, N. English, I. Trowbridge, and R. Hyman. 1995. Eur. J. Immunol. 25:495-501). Here we show that in rat pancreatic carcinoma cells, splice variants of CD44 (CD44v), but not CD44s, form molecular aggregates in the plasma membrane. We demonstrate that reduction-sensitive dimerization of CD44v occurs, and also that larger aggregations of the protein can be stabilized by chemical cross-linking. Different CD44v proteins present on the same cell exclusively form homoaggregates. Molecular clustering does not require an intact cytoplasmic domain of the protein. The ability of cells to bind to soluble HA is upregulated more than one magnitude by the ectopic expression of CD44v4-v7, but only when the CD44v4-v7 protein forms intermolecular aggregates. Tunicamycin treatment inhibits HA binding by CD44v and at the same time destroys oligomerization. We propose that the regulation of clustering of CD44, mediated by factors including the presence of variant exons and glycosylation, allows cells in turn to regulate their HA binding properties.
authors.affiliation: Forschungszentrum Karlsruhe, Institute of Genetics, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Sleeman
authors.forename: W
authors.initials: W
authors.lastname: Rudy
authors.forename: M
authors.initials: M
authors.lastname: Hofmann
authors.forename: J
authors.initials: J
authors.lastname: Moll
authors.forename: P
authors.initials: P
authors.lastname: Herrlich
authors.forename: H
authors.initials: H
authors.lastname: Ponta
mesh_terms: D017398:Alternative Splicing / Q000502:physiology; D000818:Animals; D002462:Cell Membrane / Q000737:chemistry / Q000378:metabolism; D003432:Cross-Linking Reagents / Q000494:pharmacology; D003593:Cytoplasm / Q000737:chemistry; D019281:Dimerization; D015180:Electrophoresis, Gel, Two-Dimensional; D006031:Glycosylation; D018960:Hyaluronan Receptors / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D006820:Hyaluronic Acid / Q000378:metabolism* / Q000494:pharmacology; D009842:Oligopeptides / Q000378:metabolism; D010190:Pancreatic Neoplasms; D011485:Protein Binding / Q000502:physiology; D017434:Protein Structure, Tertiary; D051381:Rats; D012995:Solubility; D014407:Tumor Cells, Cultured / Q000737:chemistry / Q000378:metabolism
chemical_list: D003432:Cross-Linking Reagents; D018960:Hyaluronan Receptors; D009842:Oligopeptides; D006820:Hyaluronic Acid